Polarean gets new polariser order from Cincinnati Children's
3rd May 2024 11:46
(Sharecast News) - Polarean Imaging announced a new polariser order to replace the research polariser at Cincinnati Children's Hospital Medical Center on Friday.
Read morePolarean gets first de novo order for Xenoview polariser
7th Dec 2023 16:01
(Sharecast News) - Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.
Read morePolarean Imaging enters strategic partnership with VIDA Diagnostics
8th Sep 2023 14:12
(Sharecast News) - Advanced MRI technology specialist Polarean Imaging announced a strategic partnership with a clinical imaging intelligence company VIDA Diagnostics on Friday.
Read morePolarean's Xenoview gets US reimbursement code
29th Aug 2023 14:22
(Sharecast News) - Medical device developer Polarean Imaging announced on Tuesday that its Xenoview technology has been granted a new reimbursement code by the US Centers for Medicare and Medicaid Services (CMS).
Read morePolarean Imaging gets first order for 'Xenoview'
26th Apr 2023 12:46
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Wednesday that it has received its first order for a gas-blend cylinder for the production of 'Xenoview', or xenon Xe 129 hyperpolarised, from Cincinnati Children's Hospital Medical Center.
Read morePolarean Imaging appoints director as strategic consultant
17th Apr 2023 12:11
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the appointment of non-executive director Daniel Brague as a consultant, with immediate effect.
Read morePolarean receives FDA approval for drug device combination product
28th Dec 2022 08:10
(Sharecast News) - Medical imaging technology group Polarean said on Wednesday that its drug device combination product has been granted approval by the US Food and Drug Administration.
Read morePolarean inks long Covid research deal with Oxford NHS trust
11th May 2022 12:58
(Sharecast News) - Medical imaging technology company Polarean announced a research collaboration with Oxford University Hospitals NHS Foundation Trust (OUH) on Wednesday, to study the long-term effects of Covid-19 in patients with breathing difficulties months after initial infection.
Read morePolarean Imaging receives research order from long-standing partner
25th Apr 2022 09:11
(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a xenon polariser '9820', it announced on Monday.
Read moreFDA accepts Polarean's medical imaging drug-device resubmission
20th Apr 2022 12:41
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on its investigational drug‑device combination product on Wednesday, which uses hyperpolarised '129Xenon' gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine.
Read morePolarean installs xenon polariser system at Vancouver hospital
11th Oct 2021 15:00
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the installation of its 9820 xenon polariser system at BC Children's Hospital in Vancouver on Monday.
Read morePolarean Imaging gets another research unit order
10th May 2021 13:49
(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a '9820 Xenon Polariser' system from the University of British Columbia (UBC), it announced on Monday.
Read moreIntuitive Investments puts £0.25m into Polarean Imaging
17th Mar 2021 14:16
(Sharecast News) - Life science-focussed closed-end investment company Intuitive Investments said on Wednesday that it was acquiring 416,666 shares of Polarean Imaging at a price of 60p each, for a total of £0.25m.
Read morePolarean Imaging new drug application gets FDA acceptance
23rd Dec 2020 11:38
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on the status of its new drug application with the US Food and Drug Administration (FDA) on Wednesday.
Read more